The effects of proprotein convertase subtilisin/kexin type 9 inhibitors on lipid metabolism and cardiovascular function

• المؤلفون الرئيسيون: Patchareeya Amput, Christian McSweeney, Siripong Palee, Arintaya Phrommintikul, Siriporn C. Chattipakorn, Nipon Chattipakorn
• التنسيق: دورية
• منشور في: 2018
• الموضوعات: Pharmacology, Toxicology and Pharmaceutics
• الوصول للمادة أونلاين: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85056208509&origin=inward; http://cmuir.cmu.ac.th/jspui/handle/6653943832/62942
• المؤسسة: Chiang Mai University

© 2018 Elsevier Masson SAS Low density lipoprotein cholesterol (LDL-C) is a well-established risk factor for cardiovascular disease. Although there are several developed lipid lowering drugs such as statins and fenofibrates, many patients do not achieve an adequate response. Recently, proprotein con...